Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

294
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
294
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

800
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
800
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

280
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
280
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

540
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
540
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

373
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
373
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

215
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
215

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Histopathological and duplex characteristics of deep venous stents: A novel microsurgical small animal model.

Vascular medicine (London, England)·2026
Same author

Better clarity on the management of pediatric acute limb ischemia.

Journal of vascular surgery·2026
Same author

Portal Vein and Superior Mesenteric Vein Thrombosis in a Patient With Antiphospholipid Syndrome and Chronic Hepatitis B.

Cureus·2026
Same author

Incentives and factors impacting costs in the surgical management of carotid disease.

Journal of vascular surgery·2026
Same author

Patency Without Payoff: Reassessing Endpoints in Infrapopliteal Peripheral Artery Disease.

Journal of the American College of Cardiology·2026
Same author

A case of an incomplete congenital sciatic artery with aberrant central venous anatomy.

Journal of vascular surgery cases and innovative techniques·2026

Related Experiment Video

Updated: Jan 17, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.7K

Predictive biomarkers for post-thrombotic syndrome.

Oscar Moreno1, Nathaniel Parchment1, Kate Micallef1

  • 1Section of Vascular Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI.

Journal of Vascular Surgery. Venous and Lymphatic Disorders
|September 24, 2025
PubMed
Summary
This summary is machine-generated.

Identifying biomarkers for post-thrombotic syndrome (PTS) is crucial. Intercellular adhesion molecule 1 and IL-10 show consistent associations with PTS development, aiding in high-risk patient identification.

Keywords:
BiomarkersDeep vein thrombosisPost-thrombotic syndrome

More Related Videos

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.8K
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

3.4K

Related Experiment Videos

Last Updated: Jan 17, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.7K
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.8K
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

3.4K

Area of Science:

  • Vascular Medicine
  • Biomarker Discovery

Background:

  • Post-thrombotic syndrome (PTS) is a chronic complication following deep venous thrombosis (DVT).
  • Identifying patients at high risk for PTS progression is essential for timely intervention.

Purpose of the Study:

  • To review and identify promising biomarker candidates for predicting the development of PTS.
  • To evaluate the consistency and reliability of various biomarkers associated with PTS progression.

Main Methods:

  • Systematic review of indexed literature, including clinical studies and review articles.
  • Analysis of associations between various biomarkers and PTS development.

Main Results:

  • Intercellular adhesion molecule 1 (ICAM-1) and Interleukin-10 (IL-10) showed consistent associations with PTS development.
  • Biomarkers such as D-dimer, C-reactive protein (CRP), and IL-6 demonstrated inconsistent results.
  • Other potential biomarkers include cell adhesion molecules, adipokines, and fibrinolytic agents, alongside novel imaging techniques.

Conclusions:

  • Further research with standardized designs is needed to validate PTS biomarkers.
  • A comprehensive panel including inflammatory, coagulation, adhesion, remodeling, and metabolic markers, adjusted for BMI and age, is recommended for future studies.